300685.SZ SHZ
Amoy Diagnostics Co., Ltd.
1W: +7.1%
1M: +23.1%
3M: +20.3%
YTD: +0.5%
1Y: -8.7%
3Y: -7.2%
5Y: -59.9%
¥21.34 ($3.18)
+0.34 (+1.62%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$2.1B
+6.7% ▲
5Y CAGR: +14.6%
Total Liabilities
$222M
-4.3% ▼
5Y CAGR: +8.9%
Shareholders Equity
$1.8B
+8.2% ▲
5Y CAGR: +15.4%
Cash & Investments
$1.2B
+15.5% ▲
5Y CAGR: +17.4%
Total Debt
$9M
-83.1% ▼
5Y CAGR: +11.8%
Net Debt
-$820M
-63.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $362M | $403M | $495M | $553M | $829M |
| Short-Term Investments | $305M | $316M | $259M | $469M | $352M |
| Cash & ST Investments | $666M | $719M | $754M | $1.0B | $1.2B |
| Net Receivables | $319M | $435M | $469M | $537M | $546M |
| Inventory | $21M | $32M | $33M | $29M | $34M |
| Other Current Assets | $3M | $11M | $30M | $33M | $15M |
| Total Current Assets | $1.0B | $1.2B | $1.3B | $1.6B | $1.8B |
| Property, Plant & Equip. | $171M | $210M | $208M | $194M | $186M |
| Goodwill & Intangibles | $16M | $19M | $47M | $49M | $44M |
| Long-Term Investments | -$234M | -$248M | -$201M | $55M | -$340M |
| Other Non-Current Assets | $312M | $323M | $304M | $12M | $376M |
| Total Non-Current Assets | $284M | $324M | $366M | $314M | $276M |
| Total Assets | $1.3B | $1.5B | $1.7B | $1.9B | $2.1B |
| — Liabilities — | |||||
| Accounts Payable | $14M | $24M | $21M | $18M | $20M |
| Short-Term Debt | $0 | $0 | $0 | $5M | $0 |
| Deferred Revenue | $9M | $108M | $65M | $0 | $0 |
| Other Current Liabilities | $128M | $102M | $6M | $10M | $53M |
| Total Current Liabilities | $150M | $135M | $92M | $174M | $195M |
| Long-Term Debt | $0 | $0 | $47M | $44M | $0 |
| Other Non-Current Liab. | -$2M | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $15M | $15M | $59M | $57M | $27M |
| Total Liabilities | $164M | $150M | $151M | $232M | $222M |
| — Equity — | |||||
| Common Stock | $222M | $222M | $398M | $399M | $398M |
| Retained Earnings | $475M | $637M | $828M | $1.0B | $1.2B |
| Accumulated OCI | $52M | $92M | $4M | $2M | $2M |
| Total Stockholders Equity | $1.1B | $1.4B | $1.5B | $1.7B | $1.8B |
| Total Liabilities & Equity | $1.3B | $1.5B | $1.7B | $1.9B | $2.1B |
| — Key Metrics — | |||||
| Total Debt | $71M | $6M | $54M | $52M | $9M |
| Net Debt | -$290M | -$397M | -$441M | -$501M | -$820M |
| Total Investments | $71M | $68M | $59M | $524M | $12M |